Progressive brain atrophy on serial MRI in dementia with Lewy Bodies, AD, and vascular dementia

Neurology

Volumn 56, Issue 10, 2001, Pages 1386-1388

  O'Brien, John T ^a   Paling, S ^a   Barber, R ^a   Williams, E D ^a   Ballard, C ^a   McKeith, I G ^a   Gholkar, A ^a   Crum, W R ^b   Rossor, M N ^b   Fox, N C ^b  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HUMAN; LEWY BODY; MALE; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0035932961     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.10.1386     Document Type: Article

References (10)

1. Perry RH, Irving D, Blessed G, et al. Senile dementia of Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119-139.
2. McKeith I, Ballard C, O'Brien J, et al. Predictive accuracy of clinical diagnostic criteria for dementia with Lewy bodies: a prospective neuropathological validation study. Neurology 2000;54:1050-1058.
3. McKeith IG, O'Brien JT, Ballard C. Diagnosing dementia with Lewy bodies. Lancet 1999;354:1227-1228.
4. Barber R, Gholkar A, Ballard C, et al. MRI volumetric study of dementia with Lewy bodies, Alzheimer's disease and vascular dementia. Neurology 2000;54:1304-1309.
5. Fox NC, Freeborough PA. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. J Magn Reson Imaging 1997;7:1069-1075.
6. Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet 1996;348:94-97.
7. Freeborough PA, Fox NC. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging 1997;16: 623-629.
8. Fox NC, Cousens S, Scahill R, Harvey RJ, et al. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol 2000;57:339-344.
9. Morris JC, Edland S, Clark C, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993;43:2457-2465.
10. Teri L, McCurry SM, Edland SD, et al. Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline. J Gerontol A Biol Sci Med Sci 1995;50A:M49-M55.